| Home \ Conferences and Programmes \ Events \ htataskforce |
|
HTA TaskforceHealth Technology Assessment (HTA) is rapidly becoming one of the most important and contentious subjects in the current discussion on global 21st century health care policies. Indeed its increasing cross-border application is having a profound effect on healthcare systems and wider societal and business environments in a growing number of countries.
Due to its enormous impact on the prioritisation and rationing of medicines, HTA is likely to remain one of the most important subjects to be discussed and dealt with at all levels of the public-policy debate. As long as no broad-based and informed debate – beyond the issue of the cost of medicines - takes place, general misunderstanding and political abuse of HTA is likely to remain. Under these circumstances, HTA has the potential to do more harm than good.
To this end, five leading market oriented think tanks have come together to create an international taskforce on the economic and political implications of this complex and crucial topic.
The new taskforce will seek to focus on the policy-making aspects of HTA by doing the following:
The founding members of the HTA taskforce include the Stockholm Network (UK), the Centre for the New Europe (Belgium), the Istituto Bruno Leoni (Italy), the Institute for Free Enterprise (Germany) and the Center for Medicine in the Public Interest (US).
.
|